Antiviral Prophylaxis in a Burn Population

Withdrawn before enrolling · Phase 2/Phase 3

Conditions studied: Herpes Simplex

In brief

A prospective, randomized trial to calculate incidence of Herpes Simplex Virus in an in-patient burn population and determine efficacy of prophylactic antiviral therapy to prevent viral infection and/or reactivation. Hypothesis is that antiviral prophylaxis will be effective in reducing HSV infection/reactivation.

Key facts

Study ID
NCT02349828
Run by
Southern Illinois University
People needed
0
Starts
2015-09-01
Expected to finish
2016-04-01
Last updated by the study team
2016-04-21

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.